Awarded
Suministro de medicamentos biológicos originales y biosimilares basadas en los principios activos adalimumab, trastuzumab, etanercept, rituximab, infliximab y bevacizumab para el Hospital Universitario Miguel Servet de Zaragoza
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- ABBVIE SPAIN, S.L., AMGEN S.A., BIOGEN SPAIN S.L., ORGANON SALUD, S.L., PFIZER SLU, Sandoz Farmaceutica
- Contract value
- €2,080,750
- Bids received
- 8
- Published
- 7 Apr 2025
- Awarded
- 4 Apr 2025
- Contract start
- 4 Apr 2025
- Contract end
- 5 Apr 2026estimated
- Region
- Zaragoza